Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial

Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial

Abstract Background Liraglutide is an antidiabetic agent with cardioprotective effect. The purpose of this study is to test efficacy of liraglutide to improve diabetic cardiomyopathy in patients with diabetes mellitus type 2 (DM2) without cardiovascular disease. Methods Patients with DM2 were random...

Full description

Bibliographic Details
Main Authors: Maurice B. Bizino, Ingrid M. Jazet, Jos J. M. Westenberg, Huub J. van Eyk, Elisabeth H. M. Paiman, Jan W. A. Smit, Hildebrandus J. Lamb
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Cardiovascular Diabetology
Subjects:
Diabetes mellitus type 2
Liraglutide
GLP1-receptor agonist
Diastolic heart failure
Cardiac function
Online Access:http://link.springer.com/article/10.1186/s12933-019-0857-6

Internet

http://link.springer.com/article/10.1186/s12933-019-0857-6

Similar Items